India IVF Treatment Market Outlook 2018

  • ID: 2699052
  • November 2013
  • Region: India
  • 54 Pages
  • Kuick Research
1 of 3

India has a large population of 1.22 Billion people and infertility in the country is rising at a rapid rate (about 30 Million couples suffer from infertility). Infertility or the inability to have children refers to a range of disorders some of which affect the male, and some the female, and contribute to childlessness in a couple.

There is also something called unexplained infertility, where doctors are unable to provide a medical explanation for the couple's inability to conceive.

In India, approximately 15%-20% of married couple s in their fertile age group, suffer from infertility and it is on the increase because of urbanization, pollution, chemical exposure, stress, competitive work environment, fast-paced lifestyles, late settlement in life, more women opting to work, increased incidence of diabetes, pelvic inflammatory diseases, etc.

Today, arrays of treatment options to treat infertility are readily available in India. These include medications for ovulation induction; endoscopic surgery to correct anatomical problems; and the assisted reproductive technologies, including IUI, IVF, and ICSI (intra cytoplasmic sperm injection).

India has become READ MORE >

Note: Product cover images may vary from those shown
2 of 3

1. What is In Vitro Fertilization (IVF) Treatment?

2. India In Vitro Fertilization (IVF) Market Overview
2.1 IVF Market Potential
2.2 IVF Treatment Cycles
2.3 IVF Clinics
2.4 Unorganized & Fragmented Market

3. India Total Fertility Rate Profile

4. Emerging In Vitro Fertilization (IVF) Market Trends
4.1 India Fertility Tourism
4.2 Technological Advances in Treatment Procedures
4.3 Changing Lifestyle Effecting Fertility Profile Among Youngsters
4.4 Infertility Rate Among Indian Couples
4.5 Investment & Foreign Collaboration

5. The Assisted Reproductive Technology (Regulation) Bill 2010
5.1 Registration & Accreditation of Clinics
5.2 Who May Apply for Registration
5.3 Grant of Registration
5.4 Renewal, Suspension or Revocation of Registration
5.5 General Duties of Assisted Reproductive Technology Clinics
5.6 Duty of Assisted Reproductive Technology Clinic to Obtain Written Consent
5.7 Duty of Assisted Reproductive Technology Clinic to Keep Accurate Records
5.8 Duties of Assisted Reproductive Technology Clinics Using Gametes & Embryos
5.9 Sourcing of Gametes
5.10 Storage and Handling of Gametes Embryos

6. Competitive Landscape
6.1 Bourn Hall
6.2 Nova Pulse IVF Clinics
6.3 Morpheus ART
6.4 Moolchand Fertility Clinic
6.5 Southend Fertility and IVF Centre
6.6 Max Reproductive Medicine and Assisted Conception
6.7 Indira Infertility Clinic
6.8 Malpani Infertility Clinic
6.9 Fortis Bloom Fertility and IVF Centre
6.10 Mediwave IVF & Fertility Hospital
6.11 Oasis Centre for Reproductive Medicine
6.12 Akanksha Fertility Clinic
6.13 Hinduja IVF Centre

List Of Tables and Figures:

Table 3-1: India Total Fertility Rate by State, 2006-2010

Figure 2-1: India IVF Market (US$ Billion), 2012-2018
Figure 2-2: IVF Treatment Market Potential by Region
Figure 2-3: Infertility Rate among Indian Women, 2012 & 2018
Figure 2-4: Number of IVF Treatment Cycles (‘000), 2012-2018
Figure 2-5: IVF Treatment Cycles Potential/Requirement (Million), 2012-2018
Figure 2-6: Average IVF Treatment Cycle Cost (US$)
Figure 2-7: Number of IVF Treatment Clinics, 2010-2018
Figure 2-8: IVF Clinic Setup Cost & Turnaround Time
Figure 2-9: Share of Organized & Unorganized Segment in IVF Market, 2012 & 2018
Figure 3-1: India Total Fertility Rate, 2000 & 2008- 2010
Figure 4-1: Average IVF Cycle Cost in India & U.S (US$)
Figure 4-2: Number of Infertile Couples in India (Million), 2010 & 2018
Figure 4-3: Share of Advance Treatment Procedures (IVF, ICSI) in Infertility Treatment Process

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: A printed copy of the report will be shipped to you.

  • Quick Help: The report will be shipped to you in CD ROM format.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.


If you have a more general question about our products please try our



Our Clients

  • Actavis
  • Smith & Nephew PLC.
  • Bayer AG
  • Hologic Inc.
  • Abbott Laboratories Ltd.
  • Polpharma SA